Related references
Note: Only part of the references are listed.Selection of Plasmodium falciparum Multidrug Resistance Gene 1 Alleles in Asexual Stages and Gametocytes by Artemether-Lumefantrine in Nigerian Children with Uncomplicated Falciparum Malaria
C. T. Happi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Artemether-Lumefantrine versus Dihydroartemisinin-Piperaquine for Falciparum Malaria: A Longitudinal, Randomized Trial in Young Ugandan Children
Emmanuel Arinaitwe et al.
CLINICAL INFECTIOUS DISEASES (2009)
Artemether-lumefantrine: an oral antimalarial for uncomplicated malaria in children
George O. Adjei et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2009)
Comparison of Sulfadoxine-Pyrimethamine, Unsupervised Artemether-Lumefantrine, and Unsupervised Artesunate-Amodiaquine Fixed-Dose Formulation for Uncomplicated Plasmodium falciparum Malaria in Benin: A Randomized Effectiveness Noninferiority Trial
Jean-Francois Faucher et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
In Vivo Selection of Plasmodium falciparum Parasites Carrying the Chloroquine-Susceptible pfcrt K76 Allele after Treatment with Artemether-Lumefantrine in Africa
Christin Sisowath et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Artemisinin-based combinations versus amodiaquine plus sulphadoxine-pyrimethamine for the treatment of uncomplicated malaria in Faladje, Mali
Kassoum Kayentao et al.
MALARIA JOURNAL (2009)
The role of ENSO in understanding changes in Colombia's annual malaria burden by region, 1960-2006
Gilma Mantilla et al.
MALARIA JOURNAL (2009)
Dihydroartemisinin-Piperaquine and Artemether-Lumefantrine for Treating Uncomplicated Malaria in African Children: A Randomised, Non-Inferiority Trial
Quique Bassat et al.
PLOS ONE (2009)
Efficacy and safety of artemether-lumefantrine dispersible tablets compared with crushed commercial tablets in African infants and children with uncomplicated malaria: a randomised, single-blind, multicentre trial
Salim Abdulla et al.
LANCET (2008)
How antimalarial drug resistance affects post-treatment prophylaxis
Nicholas J. White
MALARIA JOURNAL (2008)
The content of African diets is adequate to achieve optimal efficacy with fixed-dose artemether-lumefantrine: a review of the evidence
Zulfiqarali G. Premji et al.
MALARIA JOURNAL (2008)
Artemether-Lumefantrine versus Dihydroartemisinin-Piperaquine for Treating Uncomplicated Malaria: A Randomized Trial to Guide Policy in Uganda
Adoke Yeka et al.
PLOS ONE (2008)
Risk associated with asymptomatic parasitaemia occurring post-antimalarial treatment
Piero Olliaro et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2008)
Development and validation of an automated solid-phase extraction and liquid chromatographic method for determination of lumefantrine in capillary blood on sampling paper
D. Blessborn et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2007)
The role of pfmdr1 in Plasmodium falciparum tolerance to artemether-lumefantrine in Africa
Christin Sisowath et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2007)
Combination therapy for uncomplicated falciparum malaria in Ugandan children - A randomized trial
Grant Dorsey et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Influence of consecutive-day blood sampling on polymerase chain reaction-adjusted parasitological cure rates in an antimalarial-drug trial conducted in Tanzania
Andreas Martensson et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso
Issaka Zongo et al.
CLINICAL INFECTIOUS DISEASES (2007)
Supervised versus unsupervised antimalarial treatment with six-dose artemether-lumefantrine: pharmacokinetic and dosage-related findings from a clinical trial in Uganda
Francesco Checchi et al.
MALARIA JOURNAL (2006)
Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria
RN Price et al.
CLINICAL INFECTIOUS DISEASES (2006)
Multiplex PCR-RFLP methods for pfcrt, pfmdr1 and pfdhfr mutations in Plasmodium falciparum
MI Veiga et al.
MOLECULAR AND CELLULAR PROBES (2006)
Efficacy of artesunate plus amodiaquine versus that of artemether-lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania
A Mårtensson et al.
CLINICAL INFECTIOUS DISEASES (2005)
Supervised versus unsupervised intake of six-dose artemether-lumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda:: a randomised trial
P Piola et al.
LANCET (2005)
In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem)
C Sisowath et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number
RN Price et al.
LANCET (2004)
The evolution of drug-resistant malaria: the role of drug elimination half-life
IM Hastings et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES (2002)
Molecular evidence of greater selective pressure for drug resistance exerted by the long-acting antifolate pyrimethaminel/sulfadoxine compared with the shorter-acting chlorproguanil/dapsone on Kenyan Plasmodium falciparum
AM Nzila et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria
F Ezzet et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Vertical transmission of HIV-1 infection
ML Newell
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2000)
Share Paper
